These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17220410)

  • 21. Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface.
    Reynolds KA; Thomson JM; Corbett KD; Bethel CR; Berger JM; Kirsch JF; Bonomo RA; Handel TM
    J Biol Chem; 2006 Sep; 281(36):26745-53. PubMed ID: 16809340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
    Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,).
    Ness S; Martin R; Kindler AM; Paetzel M; Gold M; Jensen SE; Jones JB; Strynadka NC
    Biochemistry; 2000 May; 39(18):5312-21. PubMed ID: 10820001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42.
    Kotsakis SD; Caselli E; Tzouvelekis LS; Petinaki E; Prati F; Miriagou V
    Antimicrob Agents Chemother; 2013 Feb; 57(2):968-76. PubMed ID: 23229484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors.
    Morandi S; Morandi F; Caselli E; Shoichet BK; Prati F
    Bioorg Med Chem; 2008 Feb; 16(3):1195-205. PubMed ID: 17997318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae.
    Podbielski A; Schönling J; Melzer B; Warnatz K; Leusch HG
    J Gen Microbiol; 1991 Mar; 137(3):569-78. PubMed ID: 2033379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase.
    Strynadka NC; Martin R; Jensen SE; Gold M; Jones JB
    Nat Struct Biol; 1996 Aug; 3(8):688-95. PubMed ID: 8756327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of five different methods for detection of SHV extended-spectrum beta-lactamases.
    Bedenic B; Randegger C; Boras A; Haechler H
    J Chemother; 2001 Feb; 13(1):24-33. PubMed ID: 11233796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.
    Labia R; Thabaut A; Morand A; Tiwari K; Sirot D; Sirot J
    Drugs Exp Clin Res; 1989; 15(11-12):535-40. PubMed ID: 2700319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.
    Winkler ML; Rodkey EA; Taracila MA; Drawz SM; Bethel CR; Papp-Wallace KM; Smith KM; Xu Y; Dwulit-Smith JR; Romagnoli C; Caselli E; Prati F; van den Akker F; Bonomo RA
    J Med Chem; 2013 Feb; 56(3):1084-97. PubMed ID: 23252553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-Lactamase inhibitors: a review of the patent literature (2010 - 2013).
    Buynak JD
    Expert Opin Ther Pat; 2013 Nov; 23(11):1469-81. PubMed ID: 23967802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
    Powers RA; Blázquez J; Weston GS; Morosini MI; Baquero F; Shoichet BK
    Protein Sci; 1999 Nov; 8(11):2330-7. PubMed ID: 10595535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A novel extended-spectrum beta-lactamase in a ceftazidime-resistant isolate of E. coli].
    Cheng Y; Li Y; Chen M
    Wei Sheng Wu Xue Bao; 1994 Oct; 34(5):360-6. PubMed ID: 7871780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitors.
    Tondi D; Calò S; Shoichet BK; Costi MP
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3416-9. PubMed ID: 20452208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802.
    Rejiba S; Limam F; Belhadj C; Belhadj O; Ben-Mahrez K
    Microb Drug Resist; 2002; 8(1):9-13. PubMed ID: 12002654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective study of an outbreak in a Kuwaiti hospital of multidrug-resistant Klebsiella pneumoniae possessing the new SHV-112 extended-spectrum beta-lactamase.
    Dashti AA; Jadaon MM; Amyes SG
    J Chemother; 2010 Oct; 22(5):335-8. PubMed ID: 21123157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
    Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
    J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.